PANCE Exam Practice Questions: Quiz 370 April 1, 2016 By Aamir Khan Leave a Comment A 35-year-old male with documented HIV disease has completed his initial evaluation. He feels well but has a CD4 count of 198 μL and a viral load of 200,000 copies per mL. His physical examination has shown no evidence of opportunistic infection. PPD skin test, RPR, routine chemistry, CBC, lipid profile, and fasting blood sugar are all within normal limits. Which of the following is best advice? a. The patient should begin treatment with either two nucleoside analogues and nonnucleoside reverse transcriptase inhibitor or two nucleoside analogues and a protease inhibitor. b. The patient should make his own decision on beginning therapy since time of initiation does not affect mortality in an asymptomatic patient. c. The patient should consider beginning new antiviral agents such as raltegravir or maraviroc. d. Any new regimen should avoid abacavir because of its high incidence of hypersensitivity reactions. Δ
Leave a Reply